Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

BUY
$2.2 - $4.2 $192,887 - $368,239
87,676 Added 53.82%
250,572 $596,000
Q1 2022

Jun 02, 2022

BUY
$2.83 - $8.69 $460,995 - $1.42 Million
162,896 New
162,896 $657,000
Q1 2022

May 10, 2022

SELL
$2.83 - $8.69 $234,674 - $720,609
-82,924 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$8.31 - $14.92 $689,098 - $1.24 Million
82,924 New
82,924 $689,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.